Literature DB >> 32718968

Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy.

Ainara Hernando-Ortiz1, Estibaliz Mateo2, Marcelo Ortega-Riveros1, Iker De-la-Pinta1, Guillermo Quindós1, Elena Eraso1.   

Abstract

Although Candida albicans remains the major etiological agent of invasive candidiasis, Candida glabrata and other emerging species of Candida are increasingly isolated. This species is the second most prevalent cause of candidiasis in many regions of the world. However, clinical isolates of Candida nivariensis and Candida bracarensis can be misidentified and are underdiagnosed due to phenotypic traits shared with C. glabrata Little is known about the two cryptic species. Therefore, pathogenesis studies are needed to understand their virulence traits and their susceptibility to antifungal drugs. The susceptibility of Caenorhabditis elegans to different Candida species makes this nematode an excellent model for assessing host-fungus interactions. We evaluated the usefulness of C. elegans as a nonconventional host model to analyze the virulence of C. glabrata, C. nivariensis, and C. bracarensis The three species caused candidiasis, and the highest virulence of C. glabrata was confirmed. Furthermore, we determined the efficacy of current antifungal drugs against the infection caused by these species in the C. elegans model. Amphotericin B and azoles showed the highest activity against C. glabrata and C. bracarensis infections, while echinocandins were more active for treating those caused by C. nivariensis C. elegans proved to be a useful model system for assessing the pathogenicity of these closely related species.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Caenorhabditis elegans; antifungal susceptibility; antifungal susceptibility testing; candidiasis; nonconventional host model; pathogenesis

Mesh:

Substances:

Year:  2020        PMID: 32718968      PMCID: PMC7508611          DOI: 10.1128/AAC.00824-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  66 in total

Review 1.  Changes in the epidemiological landscape of invasive candidiasis.

Authors:  Frederic Lamoth; Shawn R Lockhart; Elizabeth L Berkow; Thierry Calandra
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

2.  Production of a hemolytic factor by Candida albicans.

Authors:  J M Manns; D M Mosser; H R Buckley
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

3.  [First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula].

Authors:  Leyre M López-Soria; Elena Bereciartua; Marta Santamaría; Luis Miguel Soria; José Luis Hernández-Almaraz; Alessandra Mularoni; Javier Nieto; Miguel Montejo
Journal:  Rev Iberoam Micol       Date:  2012-09-14       Impact factor: 1.044

4.  Proteomic analysis of hyperadhesive Candida glabrata clinical isolates reveals a core wall proteome and differential incorporation of adhesins.

Authors:  Emilia Gómez-Molero; Albert D de Boer; Henk L Dekker; Ana Moreno-Martínez; Eef A Kraneveld; Neeraj Chauhan; Michael Weig; Johannes J de Soet; Chris G de Koster; Oliver Bader; Piet W J de Groot
Journal:  FEMS Yeast Res       Date:  2015-11-05       Impact factor: 2.796

5.  Plate method for detection of phospholipase activity in Candida albicans.

Authors:  M F Price; I D Wilkinson; L O Gentry
Journal:  Sabouraudia       Date:  1982-03

6.  Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.

Authors:  Ronen Ben-Ami; Offer Zimmerman; Talya Finn; Sharon Amit; Anna Novikov; Noa Wertheimer; Mor Lurie-Weinberger; Judith Berman
Journal:  MBio       Date:  2016-08-02       Impact factor: 7.867

7.  Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.

Authors:  Jana Basas; Marta Palau; Xavier Gomis; Benito Almirante; Joan Gavaldà
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

8.  Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

Authors:  Michael A Pfaller; Daniel J Diekema; John D Turnidge; Mariana Castanheira; Ronald N Jones
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

9.  Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.

Authors:  Mohammad Asadzadeh; Ahlam F Alanazi; Suhail Ahmad; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

Review 10.  Caenorhabditis elegans as a Model Host to Monitor the Candida Infection Processes.

Authors:  Asmaa B Elkabti; Luca Issi; Reeta P Rao
Journal:  J Fungi (Basel)       Date:  2018-11-07
View more
  5 in total

1.  Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Aitzol Perez-Rodriguez; Piet W J de Groot; Guillermo Quindós; Elena Eraso
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

2.  Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections.

Authors:  Mohamed Hagras; Nader S Abutaleb; Ahmed M Sayed; Ehab A Salama; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

3.  In vitro and in vivo anti-Candida activity of citral in combination with fluconazole.

Authors:  Katherine Miranda-Cadena; Cristina Marcos-Arias; Aitzol Perez-Rodriguez; Iván Cabello-Beitia; Estibaliz Mateo; Elena Sevillano; Lucila Madariaga; Guillermo Quindós; Elena Eraso
Journal:  J Oral Microbiol       Date:  2022-03-02       Impact factor: 5.474

4.  Comprehensive genetic analysis of adhesin proteins and their role in virulence of Candida albicans.

Authors:  Sierra Rosiana; Liyang Zhang; Grace H Kim; Alexey V Revtovich; Deeva Uthayakumar; Arjun Sukumaran; Jennifer Geddes-McAlister; Natalia V Kirienko; Rebecca S Shapiro
Journal:  Genetics       Date:  2021-02-09       Impact factor: 4.562

5.  Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins.

Authors:  Ainara Hernando-Ortiz; Elena Eraso; Guillermo Quindós; Estibaliz Mateo
Journal:  J Fungi (Basel)       Date:  2021-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.